Sources | Names Used |
---|---|
CTRPv2 | salermide:PLX-4032 (12:1 mol/mol) |
PharmacoGx | salermide:PLX-4032 (12:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TRIM51 | CTRPv2 | pan-cancer | AAC | 0.31 | 3e-14 |
mRNA | NFATC2 | CTRPv2 | pan-cancer | AAC | 0.32 | 7e-13 |
mRNA | PLP1 | CTRPv2 | pan-cancer | AAC | 0.32 | 3e-12 |
mRNA | GAS7 | CTRPv2 | pan-cancer | AAC | 0.33 | 2e-13 |
mRNA | MIA | CTRPv2 | pan-cancer | AAC | 0.33 | 1e-14 |
mRNA | SERPINE2 | CTRPv2 | pan-cancer | AAC | 0.33 | 4e-15 |
mRNA | MIA-RAB4B | CTRPv2 | pan-cancer | AAC | 0.34 | 1e-15 |
mRNA | INPP5F | CTRPv2 | pan-cancer | AAC | 0.35 | 1e-13 |
mRNA | SDC3 | CTRPv2 | pan-cancer | AAC | 0.36 | 5e-14 |
mRNA | SOX10 | CTRPv2 | pan-cancer | AAC | 0.42 | 8e-13 |